Home / WVE : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does WVE make money? Does WVE have pricing power? What's the Earnings Whisper? Will WVE profit more as the business scales? What is WVE's management track record? Is WVE's current price justified?

Wave Life Sciences Ltd.

$4.5 -$11.45 (-71.79%)

NASDAQ · 14 Sep 2026 14:45 UTC

Previous Close

$4.59

Day Range

$4.49$4.63

Year Range

$4.49$21.73

Market Cap

886.72M

AVG Volume

3.35M

Trailing/Forward PE

-4.14/-

PEG ratio

-0.24

Dividend Yield

Next Earnings Date

2026-11-09

Primary Exchange

NASDAQ

Revenue (USD)

WVE Revenue (USD) by year
Period	Revenue (USD)
2025	42.73M
2024	108.3M
2023	113.31M
2022	3.65M
2021	40.96M
2020	20.08M
2019	15.98M
2018	14.41M
2017	3.7M
2016	1.49M

Net Income (USD)

WVE Net Income (USD) by year
Period	Net Income (USD)
2025	-204.38M
2024	-97.01M
2023	-57.51M
2022	-161.82M
2021	-122.25M
2020	-149.91M
2019	-193.64M
2018	-146.65M
2017	-102.03M
2016	-55.4M

Operating Income (USD)

WVE Operating Income (USD) by year
Period	Operating Income (USD)
2025	-215.38M
2024	-110.4M
2023	-68M
2022	-162.72M
2021	-127.02M
2020	-153.38M
2019	-208.32M
2018	-159.52M
2017	-102.58M
2016	-55.33M

EBITDA (USD)

WVE EBITDA (USD) by year
Period	EBITDA (USD)
2025	-195.53M
2024	-88.34M
2023	-50.74M
2022	-154.46M
2021	-115.05M
2020	-145.26M
2019	-199.54M
2018	-153.94M
2017	-99.49M
2016	-54.54M

Cash Flows (USD)

WVE Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-186.55M
2024	-151.96M
2023	-20.55M
2022	-129.14M
2021	-89.55M
2020	-117.32M
2019	-192.15M
2018	-32.8M
2017	-102.56M
2016	-37.44M

EPS (USD)

WVE EPS (USD) by year
Period	EPS (USD)
2025	-1.22
2024	-0.79
2023	-0.52
2022	-1.51
2021	-2.37
2020	-3.98
2019	-5.71
2018	-4.93
2017	-3.83
2016	-2.4

Expenses (USD)

WVE Expenses (USD) by year
Period	Expenses (USD)
2025	258.82M
2024	219.64M
2023	182.42M
2022	167.73M
2021	168.54M
2020	174.79M
2019	228.22M
2018	183.88M
2017	125.17M
2016	62.38M

Cash & Debt (USD)

WVE Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	602.07M
2024	302.08M
2023	200.35M
2022	88.5M
2021	150.56M
2020	184.5M
2019	147.16M
2018	174.82M
2017	142.5M
2016	150.29M

Debt ratios

WVE Debt ratios by year
Period	Debt ratios
2025	1.19
2024	0.68
2023	0.36
2022	0.08
2021	0.2
2020	0.26
2019	0.23
2018	0.5

Margins

WVE Margins by year
Period	Margins
2025	84.5%
2024	100%
2023	13.4%
2022	-3075.01%
2021	-197.52%
2020	-552.21%
2019	-997.61%
2018	-832.62%
2017	-2041.17%
2016	-2648.69%

Return on Capital

WVE Return on Capital by year
Period	Return on Capital
2025	-38.84%
2024	-46.3%
2023	-145.12%
2022	358.88%
2021	-376.16%
2020	-165.37%
2019	-270.42%
2018	-199.94%
2017	-72.98%
2016	-41.08%

Shares Outstanding

WVE Shares Outstanding by year
Period	Shares Outstanding
2025	180.15M
2024	161.49M
2023	109.63M
2022	93.99M
2021	57.01M
2020	48.78M
2019	34.3M
2018	32.6M
2017	27.82M
2016	23.49M

Book Value Per Share (USD)

WVE Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	2.92
2024	1.3
2023	0.36
2022	-0.48
2021	0.57
2020	1.86
2019	2.09
2018	2.25
2017	5.03
2016	5.74

Total Assets (USD)

WVE Total Assets (USD) by year
Period	Total Assets (USD)
2025	638.5M
2024	352.21M
2023	274.95M
2022	146.39M
2021	207.01M
2020	279.24M
2019	284.25M
2018	295.94M
2017	181.84M
2016	164.81M

Employee Count

WVE Employee Count by year
Period	Employee Count
2025	317
2024	287
2023	266
2022	250
2021	235
2020	217
2019	301
2018	250
2017	168
2016	96

Free Cash Flow Yield

WVE Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-20.08%
Sep 26	-18.96%
Aug 26	-18.28%
Aug 26	-17.42%
Aug 26	-17.03%
Aug 26	-15.11%
Jul 26	-16.72%
Jul 26	-15.76%
Jul 26	-15.74%
Jul 26	-14.65%
Jul 26	-14.63%
Jun 26	-15.71%
Jun 26	-14.87%
Jun 26	-15.6%
Jun 26	-15.98%
May 26	-13.92%
May 26	-14.36%
May 26	-13.53%
May 26	-12.76%
May 26	-12.51%
Apr 26	-14.42%
Apr 26	-13.83%
Apr 26	-14.42%
Apr 26	-14.22%
Mar 26	-16.26%
Mar 26	-8.81%
Mar 26	-7.95%
Mar 26	-7.89%
Feb 26	-7.43%
Feb 26	-8.76%
Feb 26	-9.32%
Feb 26	-8.78%
Jan 26	-9.13%
Jan 26	-8.77%
Jan 26	-8.66%
Jan 26	-8.54%
Jan 26	-7.41%
Dec 25	-6.65%
Dec 25	-7.39%
Dec 25	-7.13%
Dec 25	-15.77%
Nov 25	-15.22%
Nov 25	-16.76%
Nov 25	-16.69%
Nov 25	-15.53%
Oct 25	-13.5%
Oct 25	-17.12%
Oct 25	-15.63%
Oct 25	-16.06%
Oct 25	-17.07%
Sep 25	-17.95%
Sep 25	-17.71%
Sep 25	-17.51%
Sep 25	-14.72%
Aug 25	-12.71%
Aug 25	-12.02%
Aug 25	-12.5%
Aug 25	-15.08%
Aug 25	-14.14%
Jul 25	-13.28%
Jul 25	-13.38%
Jul 25	-14.49%
Jul 25	-16.05%
Jun 25	-16.73%
Jun 25	-16.98%
Jun 25	-16.05%
Jun 25	-15.45%
May 25	-18.56%
May 25	-18.75%
May 25	-17.62%
May 25	-16.93%
May 25	-11.62%
Apr 25	-13.98%
Apr 25	-15.9%
Apr 25	-16.66%
Apr 25	-15.61%
Mar 25	-10.92%
Mar 25	-9.81%
Mar 25	-9.21%
Mar 25	-10.01%
Feb 25	-10.21%
Feb 25	-9.69%
Feb 25	-9.98%
Feb 25	-9.66%
Jan 25	-9.33%
Jan 25	-8.98%
Jan 25	-9.82%
Jan 25	-9.35%
Jan 25	-7.99%
Dec 24	-8.36%
Dec 24	-7.99%
Dec 24	-8.03%
Dec 24	-7.07%
Nov 24	-7.15%
Nov 24	-7.01%
Nov 24	-7.32%
Nov 24	-6.09%
Nov 24	-7.24%
Oct 24	-6.93%
Oct 24	-6.54%

Price to Sales

WVE Price to Sales by year
Period	Price to Sales
Sep 26	14.19
Sep 26	15.03
Aug 26	15.58
Aug 26	16.35
Aug 26	16.73
Aug 26	18.86
Jul 26	17.03
Jul 26	16.2
Jul 26	16.23
Jul 26	17.42
Jul 26	17.45
Jun 26	16.25
Jun 26	17.17
Jun 26	16.37
Jun 26	15.97
May 26	18.34
May 26	17.79
May 26	18.87
May 26	20.02
May 26	20.41
Apr 26	30.27
Apr 26	31.58
Apr 26	30.27
Apr 26	30.7
Mar 26	26.86
Mar 26	49.58
Mar 26	54.9
Mar 26	55.32
Feb 26	58.73
Feb 26	20.72
Feb 26	19.47
Feb 26	20.65
Jan 26	19.87
Jan 26	20.69
Jan 26	20.96
Jan 26	21.25
Jan 26	24.49
Dec 25	27.29
Dec 25	24.54
Dec 25	25.43
Dec 25	11.5
Nov 25	11.92
Nov 25	10.83
Nov 25	10.87
Nov 25	13.72
Oct 25	15.78
Oct 25	12.45
Oct 25	13.63
Oct 25	13.27
Oct 25	12.48
Sep 25	11.87
Sep 25	12.03
Sep 25	12.17
Sep 25	14.47
Aug 25	16.76
Aug 25	17.72
Aug 25	17.04
Aug 25	14.12
Aug 25	15.06
Jul 25	13.01
Jul 25	12.92
Jul 25	11.93
Jul 25	10.76
Jun 25	10.33
Jun 25	10.18
Jun 25	10.76
Jun 25	11.18
May 25	9.31
May 25	9.22
May 25	9.8
May 25	10.21
May 25	12.08
Apr 25	10.04
Apr 25	8.83
Apr 25	8.42
Apr 25	8.99
Mar 25	12.85
Mar 25	14.3
Mar 25	15.24
Mar 25	14.02
Feb 25	25.92
Feb 25	27.29
Feb 25	26.51
Feb 25	27.39
Jan 25	28.37
Jan 25	29.45
Jan 25	26.95
Jan 25	28.3
Jan 25	33.13
Dec 24	31.63
Dec 24	33.13
Dec 24	32.95
Dec 24	37.44
Nov 24	37.02
Nov 24	16.73
Nov 24	16.02
Nov 24	19.27
Nov 24	16.21
Oct 24	16.94
Oct 24	17.95

Price to Book

WVE Price to Book by year
Period	Price to Book
Sep 26	2.05
Sep 26	2.17
Aug 26	2.25
Aug 26	2.36
Aug 26	2.41
Aug 26	2.72
Jul 26	2.46
Jul 26	2.27
Jul 26	2.28
Jul 26	2.44
Jul 26	2.45
Jun 26	2.28
Jun 26	2.41
Jun 26	2.3
Jun 26	2.24
May 26	2.57
May 26	2.5
May 26	2.65
May 26	2.81
May 26	2.86
Apr 26	2.46
Apr 26	2.56
Apr 26	2.46
Apr 26	2.49
Mar 26	2.18
Mar 26	4.03
Mar 26	4.46
Mar 26	4.49
Feb 26	4.77
Feb 26	18.17
Feb 26	17.08
Feb 26	18.11
Jan 26	17.43
Jan 26	18.14
Jan 26	18.38
Jan 26	18.64
Jan 26	21.48
Dec 25	23.93
Dec 25	21.52
Dec 25	22.3
Dec 25	10.09
Nov 25	10.45
Nov 25	9.49
Nov 25	9.54
Nov 25	9.26
Oct 25	10.64
Oct 25	8.4
Oct 25	9.2
Oct 25	8.95
Oct 25	8.42
Sep 25	8.01
Sep 25	8.11
Sep 25	8.21
Sep 25	9.76
Aug 25	11.3
Aug 25	11.95
Aug 25	11.49
Aug 25	9.53
Aug 25	10.16
Jul 25	7.95
Jul 25	7.89
Jul 25	7.28
Jul 25	6.57
Jun 25	6.31
Jun 25	6.22
Jun 25	6.57
Jun 25	6.83
May 25	5.69
May 25	5.63
May 25	5.99
May 25	6.23
May 25	6.24
Apr 25	5.19
Apr 25	4.56
Apr 25	4.35
Apr 25	4.65
Mar 25	6.64
Mar 25	7.39
Mar 25	7.88
Mar 25	7.25
Feb 25	9.29
Feb 25	9.79
Feb 25	9.5
Feb 25	9.82
Jan 25	10.17
Jan 25	10.56
Jan 25	9.66
Jan 25	10.15
Jan 25	11.88
Dec 24	11.34
Dec 24	11.88
Dec 24	11.82
Dec 24	13.42
Nov 24	13.28
Nov 24	420.37
Nov 24	402.69
Nov 24	484.29
Nov 24	407.4
Oct 24	425.67
Oct 24	451

No video analysis for this stock yet. Request one from our team.

News: WVE

globenewswire.com · 3 Sep 2026

Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference

CAMBRIDGE, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd.

247wallst.com · 13 Aug 2026

Wave Life Sciences: A $1 Billion RNA-Medicine Bargain Ripe for Pharma Takeover

Wave Life Sciences (NASDAQ:WVE) trades at $5.24, a step above its 52-week low of $5.01 and far beneath the 52-week high of $21.73.

seekingalpha.com · 11 Aug 2026

Wave Life Sciences Ltd. (WVE) Presents at Bank of America SMID Cap Virtual Conference Transcript

globenewswire.com · 10 Aug 2026

Wave Life Sciences Announces Completion of Redomiciliation to Delaware

CAMBRIDGE, Mass., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health (“Wave” or “Wave Life Sciences”), today announced the completion of the redomiciliation process to change the parent company of the Wave group of companies from a Singapore company to a Delaware corporation by way of a statutory procedure known as a scheme of arrangement under Section 210 of the Companies Act 1967 of Singapore (the “Redomiciliation”).

globenewswire.com · 5 Aug 2026

Wave Life Sciences Announces Expected Completion Date for Redomiciliation to Delaware

CAMBRIDGE, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) -- As previously announced, Wave Life Sciences Ltd.

globenewswire.com · 4 Aug 2026

Wave Life Sciences to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that members of Wave's management team are scheduled to participate in two upcoming investor conferences in August.

marketbeat.com · 30 Jul 2026

WAVE Life Sciences Q2 Earnings Call Highlights

WAVE Life Sciences NASDAQ: WVE reported a wider second-quarter loss as it increased investment in its obesity and RNA-editing programs, while outlining several clinical and regulatory milestones expected in the second half of 2026.

seekingalpha.com · 30 Jul 2026